|Articles|April 29, 2008
Premier and Octagon Announce Strategic Partnership
A new partnership between Premier Research Group and Octagon Research Solutions will expand the companies' solution sets.
Advertisement
Philadelphia, PA-April 29, 2008-Premier Research Group (www.premier-research.com ), the international pharmaceutical services group, and Octagon Research Solutions ( www.octagonresearch.com ), a leader in the electronic transformation of clinical R&D in the life sciences industry, today announce the formalization of a partnership agreement to provide a broader solution set.
This new partnership combines Octagon’s expertise in electronic submissions with Premier Research’s extensive clinical expertise across a wide array of therapeutic areas. The partnership enables Premier Research to offer Octagon’s electronic submission capabilities as part of its Regulatory Affairs services and for Octagon to offer Premier’s regulatory development and scientific strategy.
James Ottinger, vice president of global consulting and compliance for Premier Research noted, “Our partnership with Octagon broadens our services by offering Octagon’s proven expertise in the technical aspects of electronic submissions while we continue to focus on our core strengths of regulatory strategy and consulting. We are pleased to be working with an organization that also values our deep commitment to being a ‘solution provider’ for our clients.”
“Premier Research has a solid history of consistent, quality delivery that aligns with our own high standard of operation. We believe that the collaboration will ultimately provide a strong product for our valued customers,” commented Jim Walker, chairman and chief excutive officer, Octagon Research Solutions.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- NIMBLE Trial Reveals New Insights on Complement Inhibition in gMG
September 15th 2025
- Q&A: Strategies for Successful Global Clinical Trial Delivery
September 12th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Capvaxive Demonstrates Robust Immune Responses in Children, Adolescents at Increased Risk of Pneumococcal Disease
2
ACT Brief Weekly Recap: How AI, eClinical Innovation, and Policy Shifts Are Reshaping Clinical Research
3
NIMBLE Trial Reveals New Insights on Complement Inhibition in gMG
4
Phase IV Trial Shows Daybue Demonstrates Real-World Behavioral Improvements in Rett Syndrome
5